Shareholder Vote

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported):  June 20, 2019 Balchem Corporation (Exact name of registrant as specified in its charter) Maryland 1-13648 13-2578432 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 52 Sunrise Park Road, New Hampton, NY 10958 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (845) 326-5600 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered   Common Stock, par value $.06-2/3 per share.   BCPC   NASDAQ Global Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Item 5.07 -  Submission of Matters to a Vote of Security Holders The Company held its Annual Meeting of Stockholders on June 20, 2019 (“ Annual Meeting ”).  Set forth below is information regarding the results of the matters voted on by stockholders at the Annual Meeting: (i)         Election of two Class 1 Directors to serve to serve until the annual Company’s meeting of stockholders in 2022 and thereafter until their respective successors are elected and qualified: Director Nominee Votes For Votes Withheld Theodore L. Harris 26,949,624 1,150,978 Matthew D. Wineinger 17,387,777 10,712,825 (ii)        Ratification of the appointment of RSM LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2019:  30,465,974 shares in favor; 262,573 shares against; 6,884 shares abstaining. (iii)       Advisory vote to approve the Company’s executive compensation: 26,557,862 shares in favor; 1,514,004 shares against; 28,736 shares abstaining; and 2,634,829 broker non-votes. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.   BALCHEM CORPORATION       By:/s/ Mark Stach   Mark Stach, General Counsel and Secretary     Dated: June 21, 2019